Pluspunten
Strong pipeline of copycat biosimilars
Minpunten
Terrible Korean leadership, weak HR, a compliance team that has zero knowledge of pharma, refusal to listen to the Americans, horrible distrustful culture, ride alongs too frequent, constant firing of Americans but refusal to fire Koreans who are bad workers, CEO can't even speak English.